Latest Breaking News On - Tubutecan adcs - Page 1 : comparemela.com

Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024

Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesTubuli tubutecanDennis riedlJonas helma smetsTubutecan adcsDominik schumacherTrophic communicationsAnnual meetingAmerican associationCancer researchChief scientific officerFc silenced igg

Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024

Tubulis today presented comprehensive preclinical data on its two lead antibody-drug conjugate (ADC) candidates TUB-030 and TUB-040 at this year's Annual Meeting of the American Association for Cancer Research (AACR) in San Diego. The poster.

San diegoUnited statesTubuli tubutecanJonas helma smetsTubutecan adcsProduct servicePresents preclinical dataSolid tumor targetingSuperior efficacy profileWide therapeutic windowAnnual meetingAmerican associationCancer researchChief scientific officerFc silenced igg